152 related articles for article (PubMed ID: 22902076)
1. p53R2 is a prognostic factor of melanoma and regulates proliferation and chemosensitivity of melanoma cells.
Matsushita S; Ikeda R; Fukushige T; Tajitsu Y; Gunshin K; Okumura H; Ushiyama M; Akiyama S; Kawai K; Takeda Y; Yamada K; Kanekura T
J Dermatol Sci; 2012 Oct; 68(1):19-24. PubMed ID: 22902076
[TBL] [Abstract][Full Text] [Related]
2. Metastasis-suppressing potential of ribonucleotide reductase small subunit p53R2 in human cancer cells.
Liu X; Zhou B; Xue L; Shih J; Tye K; Lin W; Qi C; Chu P; Un F; Wen W; Yen Y
Clin Cancer Res; 2006 Nov; 12(21):6337-44. PubMed ID: 17085643
[TBL] [Abstract][Full Text] [Related]
3. Silencing of the p53R2 gene by RNA interference inhibits growth and enhances 5-fluorouracil sensitivity of oral cancer cells.
Yanamoto S; Iwamoto T; Kawasaki G; Yoshitomi I; Baba N; Mizuno A
Cancer Lett; 2005 Jun; 223(1):67-76. PubMed ID: 15890238
[TBL] [Abstract][Full Text] [Related]
4. Ribonucleotide reductase small subunit p53R2 facilitates p21 induction of G1 arrest under UV irradiation.
Xue L; Zhou B; Liu X; Heung Y; Chau J; Chu E; Li S; Jiang C; Un F; Yen Y
Cancer Res; 2007 Jan; 67(1):16-21. PubMed ID: 17210678
[TBL] [Abstract][Full Text] [Related]
5. P53R2, p53 inducible ribonucleotide reductase gene, correlated with tumor progression of non-small cell lung cancer.
Uramoto H; Sugio K; Oyama T; Hanagiri T; Yasumoto K
Anticancer Res; 2006; 26(2A):983-8. PubMed ID: 16619496
[TBL] [Abstract][Full Text] [Related]
6. Ribonucleotide reductase subunits M2 and p53R2 are potential biomarkers for metastasis of colon cancer.
Liu X; Zhou B; Xue L; Yen F; Chu P; Un F; Yen Y
Clin Colorectal Cancer; 2007 Jan; 6(5):374-81. PubMed ID: 17311703
[TBL] [Abstract][Full Text] [Related]
7. Expression status of ribonucleotide reductase small subunits hRRM2/p53R2 as prognostic biomarkers in stage I and II non-small cell lung cancer.
Hsu NY; Wu JY; Liu X; Yen Y; Chen CY; Chou MC; Lin CH; Lee H; Cheng YW
Anticancer Res; 2011 Oct; 31(10):3475-81. PubMed ID: 21965764
[TBL] [Abstract][Full Text] [Related]
8. Expression of p53R2 is related to prognosis in patients with esophageal squamous cell carcinoma.
Okumura H; Natsugoe S; Yokomakura N; Kita Y; Matsumoto M; Uchikado Y; Setoyama T; Owaki T; Ishigami S; Aikou T
Clin Cancer Res; 2006 Jun; 12(12):3740-5. PubMed ID: 16778101
[TBL] [Abstract][Full Text] [Related]
9. Improvement in radiosensitivity using small interfering RNA targeting p53R2 in esophageal squamous cell carcinoma.
Yokomakura N; Natsugoe S; Okumura H; Ikeda R; Uchikado Y; Mataki Y; Takatori H; Matsumoto M; Owaki T; Ishigami S; Aikou T
Oncol Rep; 2007 Sep; 18(3):561-7. PubMed ID: 17671702
[TBL] [Abstract][Full Text] [Related]
10. Ribonucleotide reductase small subunit p53R2 suppresses MEK-ERK activity by binding to ERK kinase 2.
Piao C; Jin M; Kim HB; Lee SM; Amatya PN; Hyun JW; Chang IY; You HJ
Oncogene; 2009 May; 28(21):2173-84. PubMed ID: 19398949
[TBL] [Abstract][Full Text] [Related]
11. A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage.
Tanaka H; Arakawa H; Yamaguchi T; Shiraishi K; Fukuda S; Matsui K; Takei Y; Nakamura Y
Nature; 2000 Mar; 404(6773):42-9. PubMed ID: 10716435
[TBL] [Abstract][Full Text] [Related]
12. Ribonucleotide reductase small subunit p53R2 promotes oral cancer invasion via the E-cadherin/beta-catenin pathway.
Yanamoto S; Kawasaki G; Yamada S; Yoshitomi I; Yoshida H; Mizuno A
Oral Oncol; 2009 Jun; 45(6):521-5. PubMed ID: 18804405
[TBL] [Abstract][Full Text] [Related]
13. p53R2 inhibits the proliferation of human cancer cells in association with cell-cycle arrest.
Zhang K; Wu J; Wu X; Wang X; Wang Y; Zhou N; Kuo ML; Liu X; Zhou B; Chang L; Ann D; Yen Y
Mol Cancer Ther; 2011 Feb; 10(2):269-78. PubMed ID: 21216934
[TBL] [Abstract][Full Text] [Related]
14. Expression and mutation analyses of P53R2, a newly identified p53 target for DNA repair in human gastric carcinoma.
Byun DS; Chae KS; Ryu BK; Lee MG; Chi SG
Int J Cancer; 2002 Apr; 98(5):718-23. PubMed ID: 11920641
[TBL] [Abstract][Full Text] [Related]
15. Disruption of the p53-p53r2 DNA repair system in ulcerative colitis contributes to colon tumorigenesis.
Yoshida T; Haga S; Numata Y; Yamashita K; Mikami T; Ogawa T; Ohkusa T; Okayasu I
Int J Cancer; 2006 Mar; 118(6):1395-403. PubMed ID: 16206288
[TBL] [Abstract][Full Text] [Related]
16. Suppression of p53R2 gene expression with specific siRNA sensitizes HepG2 cells to doxorubicin.
Azimi A; Majidinia M; Shafiei-Irannejad V; Jahanban-Esfahlan R; Ahmadi Y; Karimian A; Mir SM; Karami H; Yousefi B
Gene; 2018 Feb; 642():249-255. PubMed ID: 29126924
[TBL] [Abstract][Full Text] [Related]
17. Regulation of p53R2 and its role as potential target for cancer therapy.
Wang X; Zhenchuk A; Wiman KG; Albertioni F
Cancer Lett; 2009 Apr; 276(1):1-7. PubMed ID: 18760875
[TBL] [Abstract][Full Text] [Related]
18. The roles of p53R2 in cancer progression based on the new function of mutant p53 and cytoplasmic p21.
Yousefi B; Rahmati M; Ahmadi Y
Life Sci; 2014 Mar; 99(1-2):14-7. PubMed ID: 24486301
[TBL] [Abstract][Full Text] [Related]
19. Gallic acid inhibits the migration and invasion of A375.S2 human melanoma cells through the inhibition of matrix metalloproteinase-2 and Ras.
Lo C; Lai TY; Yang JS; Yang JH; Ma YS; Weng SW; Lin HY; Chen HY; Lin JG; Chung JG
Melanoma Res; 2011 Aug; 21(4):267-73. PubMed ID: 21734530
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]